BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3896153)

  • 1. [Subrenal capsule assay, a new sensitivity test for antitumor agents].
    Sakai Y
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1535-51. PubMed ID: 3896153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay].
    Inoue K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The subrenal capsule assay modified with three-dimensional measurement (volume method) and its higher predictivity].
    Sakai Y; Sasaki T; Imai K; Ibuka T; Koike M; Iwamoto S
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2431-43. PubMed ID: 3619456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice].
    Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
    Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
    Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental evaluation of the subrenal capsule assay as an in vivo chemosensitivity test].
    Fujita M; Kusuyama T; Taguchi T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2417-22. PubMed ID: 3619454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system].
    Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1227-34. PubMed ID: 3729446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subrenal capsule assay (SRCA) using human lung cancer].
    Kudoh S; Kurihara N; Mizoguchi S; Ueda Y; Adachi N; Hiraga T; Yamamoto M; Hirata K; Ohta K; Fujimoto S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2743-9. PubMed ID: 3415270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
    Fukui H; Ide H; Hanyu F; Ikemoto H; Okushima N; Murata Y; Sato Y; Yamada A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1106-10. PubMed ID: 2436579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of the subrenal capsule assay (SRCA) and related problems].
    Yamada H; Toh K; Saku M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2450-7. PubMed ID: 3619458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subrenal capsule assay for chemosensitivity testing].
    Kusuyama T; Fujita M; Shimozuma K; Orikasa H; Usugane M; Taguchi T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1143-9. PubMed ID: 3105468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trials of the subrenal capsule assay].
    Niimoto M; Nishiyama M; Takagami S; Niimi K; Saeki T; Yoshinaka K; Hattori T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2444-9. PubMed ID: 3619457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment.
    Aamdal S; Fodstad O; Pihl A
    Ann Chir Gynaecol Suppl; 1985; 199():51-9. PubMed ID: 3864392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical responses in comparison with the results of the chemosensitivity test by subrenal capsule assay].
    Inoue K; Wang Y; Itoh Y; Shibata H; Chen SC; Ogawa M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2305-9. PubMed ID: 3606150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on subrenal capsule assay for predicting individual tumor chemosensitivity].
    Nishiyama M
    Nihon Geka Gakkai Zasshi; 1987 Feb; 88(2):152-62. PubMed ID: 3574273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
    Terashima M; Ikeda K; Kawamura S; Takagane A; Maesawa C; Sudoh T; Okamoto K; Ishida K; Satoh M; Saito K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):269-73. PubMed ID: 2405778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the 6-day subrenal capsule assay for sensitivity testing of antineoplastic chemotherapy in oral mucosa carcinoma].
    Fröhlich M; Rositzka R; Neubauer B
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(5):427-32. PubMed ID: 2529712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.
    Edelstein MB; Smink T; van Putten LM
    Behring Inst Mitt; 1984 May; (74):285-90. PubMed ID: 6477357
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the effectiveness of antitumor preparations in human lung cancer xenografts growing on mice in diffusion chambers].
    Krutova TV; Korman DB; Potapov IuN; Pashkova VS
    Izv Akad Nauk SSSR Biol; 1984; (6):901-8. PubMed ID: 6097608
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
    Aamdal S; Fodstad O; Pihl A
    Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.